Heart Disease is in the Eye of the Beholder
Researchers at UC San Diego Health see a possible way to detect heart disease through the eye.
School of Medicine
The Latest
Repurposed Arthritis Drug Did Not Significantly Improve Severe COVID-19 Pneumonia
A repurposed drug used to treat arthritis did not significantly improve the outcomes of patients with severe COVID-19 pneumonia. Tocilizumab did not significantly improve clinical status or mortality rate at 28 days for participants who received it compared to a placebo.
NIH Awards UC San Diego $33 Million for Five COVID-19 Diagnostic Projects
UC San Diego was awarded five COVID-19 Rapid Acceleration of Diagnostics (RADx) projects by the National Institutes of Health totaling nearly $33 million, which will fund efforts that range from managing a large data center to expanding testing in disadvantaged communities.
Human Lung and Brain Organoids Respond Differently to SARS-CoV-2 Infection in Lab Tests
UC San Diego School of Medicine researchers are using stem cell-derived organoids to study how SARS-CoV-2 interacts with various organ systems. Their findings may help explain the wide variety in COVID-19 symptoms and aid the search for therapies.
You’ve Got to Move It, Move It
Research from Herbert Wertheim School of Public Health and Human Longevity Science at UC San Diego suggests that light-intensity physical activity, including shopping or a casual walk, may protect against mobility disability in older women.
Genetic Tool Improves Estimation of Prostate Cancer Risk in Diverse Ethnic/Racial Groups
Scientists at University of California San Diego School of Medicine validated a more inclusive and comprehensive genetic tool, known as a polygenic hazard score (PHS), for predicting age of onset of aggressive prostate cancer.
Trending Stories
In the Media
Stay in the Know
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
